Onderzoeksgroep Geestelijke Gezondheid en Welbevinden

Medicine & Life Sciences

1. Belgium 100%
2. Tuberous Sclerosis 98%
3. Euthanasia 40%
4. Epilepsy 34%
5. Physicians 30%
6. Substance-Related Disorders 30%
7. Polymicrogyria 27%
8. Nursing Homes 24%
9. Attention Deficit Disorder with Hyperactivity 23%
10. General Practitioners 22%
11. Child 22%
12. HIV 21%
13. Nurses 20%
14. Acquired Immunodeficiency Syndrome 20%
15. Mental Health 19%
16. Seizures 18%
17. Phenotype 18%
18. Brain 17%
19. Assisted Suicide 17%
20. Microcephaly 17%
21. Mutation 17%
22. Decision Making 16%
23. Delivery of Health Care 16%
24. Therapeutics 15%
25. Registries 15%
26. Emotions 15%
27. Psychiatry 14%
28. Guidelines 14%
29. Autism Spectrum Disorder 14%
30. Focus Groups 13%
31. Systematic Reviews 13%
32. Malformations of Cortical Development 13%
33. Genes 12%
34. General Practice 12%
35. Vagus Nerve 12%
36. Neoplasms 12%
37. Caregivers 11%
38. Consensus 11%
39. Uganda 11%
40. Interviews 11%
41. Referral and Consultation 10%
42. Intellectual Disability 10%
43. Palliative Care 10%
44. Communication 10%
45. Antidepressive Agents 9%
46. Alcohols 9%
47. Population 9%
48. Conflict (Psychology) 9%
49. Coronavirus 9%
50. Angiomyolipoma 9%
51. Psychological Stress 9%
52. Electroencephalography 9%
53. Brain Neoplasms 8%
54. Heart Rate 8%
55. Suicide 8%
56. Critical Care 8%
57. Prescriptions 8%
58. Genetic Association Studies 8%
59. Genotype 7%
60. Pain 7%
61. Education 7%
62. Survivors 7%
63. Magnetic Resonance Imaging 7%
64. Depression 7%
65. Mental Health Associations 7%
66. Familial Hypophosphatemic Rickets 7%
67. Natural History 7%
68. Health Personnel 7%
69. Pandemics 6%
70. Health 6%
71. Psychotherapy 6%
72. University Hospitals 6%
73. Consciousness 6%
74. Intensive Care Units 6%
75. Neurodevelopmental Disorders 6%
76. Lissencephaly 6%
77. Nursing 6%
78. Cross-Sectional Studies 6%
79. Randomized Controlled Trials 6%
80. Brain Diseases 6%
81. Primary Health Care 6%
82. Parents 6%
83. Observational Studies 6%
84. Checklist 6%
85. Periventricular Nodular Heterotopia 6%
86. Comorbidity 6%
87. Tubulin 5%
88. Everolimus 5%
89. Neuropathology 5%
90. Kidney 5%
91. Anxiety 5%
92. Pain Measurement 5%
93. Minority Groups 5%
94. von Hippel-Lindau Disease 5%
95. Ergonomics 5%
96. Psychological Burnout 5%
97. Noncommunicable Diseases 5%
98. Corpus Callosum 5%
99. Basal Ganglia 5%
100. France 5%